Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Showing fund managers & funds registered for sale globally. You can filter by individual jurisdictions.

Funds & Fund Managers

All calculations in USD, unless stated
over :
 Average Total Return : 20.6% (31 December 2016 - 31 December 2017)
Currency Total Return Standard Deviation Max Drawdown
1 of 142

UIT Alternative Health Series A

USD

53.3%

26.0

-8.2%

2 of 142

Biotech Opportunities Fund P USD

USD

47.2%

14.8

-3.0%

3 of 142

Eventide Healthcare & Life Sciences Fund;A

USD

45.5%

17.4

-7.1%

4 of 142

C WorldWide Medical Small & Mid Cap

USD

43.2%

22.5

-7.0%

5 of 142

Perinvest (Lux) Sicav Gl Healthcare Eq A EUR Cap

USD

39.0%

9.2

-2.0%

6 of 142

Alger Health Sciences Fund;A

USD

37.2%

12.6

-1.7%

7 of 142

HealthInvest Small & MicroCap Fund

USD

36.9%

8.5

-2.4%

8 of 142

RIM Global Fund Bioscience B

USD

35.7%

13.0

-3.7%

9 of 142

Lacuna - BB Adamant Asia Pacific Health P

USD

35.1%

6.9

-1.2%

10 of 142

Performance Vitae A

USD

33.9%

14.5

-3.2%

11 of 142

BOCIP China Health Care A

USD

32.9%

11.0

-3.7%

12 of 142

Delaware Healthcare Fund;A

USD

32.0%

6.9

-0.8%

13 of 142

BB Adamant Global Medtech und Services AA Klasse

USD

31.9%

9.2

-2.2%

14 of 142

Prudential Jennison Health Sciences Fund;Z

USD

31.4%

14.4

-4.4%

15 of 142

The Montreux Healthcare B GBP

USD

31.2%

9.8

-0.7%

16 of 142

nova Steady HealthCare - P

USD

30.0%

7.9

-1.7%

17 of 142

apo Medical Opportunities Institutionell

USD

29.7%

7.7

-3.2%

18 of 142

Bellevue F (Lux) BB Adamant Medtech B EUR

USD

29.6%

7.8

-1.8%

19 of 142

Lacuna - BB Adamant Global Healthcare I

USD

29.3%

5.4

-0.6%

20 of 142

apo Medical Opportunities R

USD

28.9%

7.2

-2.3%

21 of 142

Mirae Asset Asia Pacific Health Care Opps Eq I USD

USD

28.5%

9.4

-2.4%

22 of 142

SWC (CH) EF Global Health Care AA CHF

USD

28.4%

6.0

-0.5%

23 of 142

T Rowe Price Health Sciences Fund

USD

28.0%

9.2

-0.9%

24 of 142

BB Adamant Global Generika AA Klasse

USD

27.3%

7.7

-1.8%

25 of 142

Handelsbanken Lakemedelsfond (A1 SEK)

USD

26.7%

5.3

-0.1%

26 of 142

Arctic Aurora LifeScience I

USD

26.6%

13.8

-6.2%

26 of 142

AB SICAV I-International Health Care Pf I USD

USD

26.6%

5.4

-0.7%

28 of 142

Fidelity Select Medical Technology and Devices Ptf

USD

26.6%

10.4

-3.4%

29 of 142

MIV Global Medtech Fund P1

USD

26.4%

8.5

-2.2%

30 of 142

TD Health Sciences Investor Series

USD

25.6%

9.3

-1.6%

31 of 142

GAM Multistock - Health Innovation Eq-USD B

USD

25.3%

16.7

-6.9%

32 of 142

BlackRock Health Sciences Opportunities Port;Inv A

USD

24.8%

7.6

-1.0%

33 of 142

Fidelity Advisor Health Care Fund;I

USD

24.4%

10.7

-1.6%

34 of 142

Fidelity Select Health Care Services Portfolio

USD

24.3%

9.6

-1.4%

35 of 142

KBC Equity Medical Technologies Cap

USD

24.2%

7.4

-1.6%

36 of 142

Fidelity Select Health Care Portfolio

USD

24.0%

10.9

-1.7%

37 of 142

KMG Valais Medical Opportunities A USD

USD

23.9%

13.7

-7.1%

38 of 142

PBP Biogen, FI

USD

23.8%

8.1

-4.0%

39 of 142

Polar Capital Healthcare Opportunities USD

USD

23.8%

9.8

-1.8%

40 of 142

Aberdeen (Swiss) Funds Global Pharma Equity Fd

USD

23.7%

6.2

-0.3%

41 of 142

Rydex Health Care Fund;Investor

USD

23.5%

8.1

-1.1%

42 of 142

Janus Henderson Global Life Sciences Fund;D

USD

22.6%

8.9

-3.5%

43 of 142

BSO Bio Sante

USD

22.6%

8.2

-3.9%

44 of 142

LahiTapiola Hyvinvointi A

USD

22.4%

6.9

-2.1%

45 of 142

Platinum International Health Care

USD

22.4%

6.6

-1.2%

46 of 142

CFS FC W Inv-CFS W Global Health & Biotechnology

USD

22.0%

9.9

-2.1%

47 of 142

Hartford Healthcare HLS;IB

USD

22.0%

9.7

-2.9%

48 of 142

NN Health Care Fund

USD

21.9%

6.9

-2.1%

49 of 142

BGF World Healthscience A2 USD

USD

21.8%

7.4

-0.3%

49 of 142

Ohman Hjart-Lungfonden

USD

21.8%

6.0

-1.8%

51 of 142

Wellington Global Health Care Equity USD G Acc Unh

USD

21.6%

10.1

-1.9%

52 of 142

Hartford Healthcare Fund;A

USD

21.6%

9.6

-2.8%

53 of 142

DNB Health Care

USD

21.4%

6.4

-1.0%

54 of 142

SEB Lakemedelsfond

USD

21.3%

6.3

-1.1%

55 of 142

PHARMA/wHEALTH -R (USD)-

USD

21.3%

8.3

-1.0%

56 of 142

PPF - PMG Global Biotech I

USD

21.2%

13.1

-6.8%

57 of 142

Janus Henderson Global Life Sciences - A$acc

USD

20.6%

8.8

-3.6%

58 of 142

LBPAM Actions Sante + R

USD

20.4%

8.1

-3.5%

59 of 142

Belfius Equities Global Health Care C Cap

USD

20.3%

6.6

-2.0%

60 of 142

Argenta Actions Pharma-Chimie R Cap

USD

20.3%

9.0

-3.0%

61 of 142

Schwab Health Care Fund

USD

20.2%

6.9

-2.5%

62 of 142

JPM Global Healthcare A Acc USD

USD

20.1%

7.4

-2.3%

63 of 142

NN (L) Health Care P Cap USD

USD

20.0%

7.1

-2.4%

64 of 142

Janus Global Life Sciences Fund Portfolio B Units

USD

19.9%

10.7

-3.1%

65 of 142

Vanguard Health Care Fund;Investor

USD

19.6%

7.8

-1.7%

65 of 142

United Global Healthcare Fund-Class SGD (Acc)

USD

19.6%

10.0

-2.2%

67 of 142

apo Medical Balance R

USD

19.6%

6.7

-2.9%

68 of 142

ClearBridge Global Health Care Innovations Fund;IS

USD

19.5%

10.5

-4.5%

69 of 142

Deutsche Health and Wellness Fund;S

USD

19.3%

8.4

-2.1%

70 of 142

Schoellerbank Global Health Care

USD

19.2%

7.3

-1.7%

71 of 142

Subfundusz UniAkcje Biopharma

USD

18.8%

7.6

-3.3%

72 of 142

SEB Medical

USD

18.8%

6.0

-0.9%

73 of 142

Fidelity Funds - Global Health Care A-EUR

USD

18.8%

6.2

-0.4%

74 of 142

VP Health Care HKD A

USD

18.8%

4.6

-0.3%

75 of 142

Fidelity Global Health Care Class Series B

USD

18.7%

6.1

-0.5%

76 of 142

Fidelity Global Health Care Fund Series B

USD

18.7%

6.1

-0.5%

77 of 142

Invesco Global Health Sciences Fund

USD

18.7%

7.5

-0.8%

78 of 142

Caixabank Multisalud Estandar, FI

USD

18.5%

7.0

-2.0%

79 of 142

DekaLux-PharmaTech CF

USD

18.4%

6.5

-1.1%

80 of 142

Sector Healthcare Value A USD

USD

18.4%

6.5

-2.0%

81 of 142

Pioneer Funds Austria - Healthcare Stock A

USD

18.4%

6.7

-1.5%

82 of 142

DWS Health Care Typ 0 NC

USD

18.0%

7.0

-1.6%

83 of 142

Polar Capital Healthcare Blue Chip I USD Acc

USD

17.7%

7.0

-1.4%

84 of 142

Schroder Global Healthcare A Acc

USD

17.6%

6.7

-1.5%

85 of 142

VS - Sectoral EM Health Care Fund P - ACCU - USD

USD

17.4%

6.1

-2.3%

86 of 142

Eurizon Azioni Salute

USD

17.3%

6.7

-2.2%

87 of 142

AllianzGI Health Sciences Fund;A

USD

17.3%

8.4

-2.8%

88 of 142

Raiffeisen-HealthCare-Aktien R A

USD

17.3%

7.2

-1.9%

89 of 142

Danske Invest MediLife Kasvu

USD

16.9%

8.1

-3.1%

90 of 142

Etoile Sante Europe C

USD

16.8%

9.6

-5.0%

91 of 142

DKB Pharma Fonds AL

USD

16.6%

6.3

-1.6%

92 of 142

DSC Equity Fund - Healthcare (A)

USD

16.3%

7.4

-2.1%

93 of 142

Eaton Vance Worldwide Health Sciences Fund;A

USD

16.2%

8.1

-3.4%

94 of 142

Investors Global Health Care Class Series A

USD

16.2%

7.6

-2.9%

95 of 142

Montepio Euro Healthcare

USD

16.2%

10.3

-6.2%

96 of 142

Trecento Sante EUR

USD

16.1%

5.7

-1.4%

97 of 142

C WorldWide Medical

USD

15.9%

11.0

-3.7%

98 of 142

C WorldWide Medical EUR

USD

15.8%

10.6

-3.6%

99 of 142

Infond Life

USD

15.7%

6.5

-2.1%

100 of 142

UBS (Lux) Equity Fund - Health Care (USD) P-acc

USD

15.6%

8.0

-2.7%

101 of 142

Manulife Global Fd-Healthcare AA

USD

15.5%

7.5

-1.6%

102 of 142

Invesco Global Health Care Fund;A

USD

15.5%

10.0

-3.8%

103 of 142

Crossfund Sicav-Crossinvest Healthcare A USD

USD

15.4%

7.6

-1.6%

104 of 142

Nikko AM Asia Healthcare JPY

USD

15.4%

11.1

-7.4%

105 of 142

Putnam Global Health Care Fund;A

USD

15.3%

7.6

-2.6%

106 of 142

Pictet-Health-P USD

USD

15.1%

8.3

-3.0%

107 of 142

DP Salud, FI

USD

15.1%

6.8

-3.0%

108 of 142

Global Healthcare Dividend Series A

USD

14.9%

6.4

-2.7%

109 of 142

Lux-Equity Pharma & Health Care

USD

14.9%

8.3

-4.3%

110 of 142

Reliance Pharma Fund-Growth

USD

14.4%

15.3

-9.6%

111 of 142

Invesco Global Health Care A Annual Dist USD

USD

14.4%

11.4

-2.4%

112 of 142

IKC Global Healthcare A

USD

14.3%

6.5

-2.8%

113 of 142

AXA Framlington Health R Inc

USD

14.2%

8.0

-3.5%

114 of 142

KBC Equity Pharma Cap

USD

14.2%

7.5

-3.4%

115 of 142

Iris Sante

USD

13.9%

9.3

-6.2%

116 of 142

CI Global Health Sciences Corp Cl A

USD

13.9%

11.6

-4.5%

117 of 142

Fondsfinans Global Helse

USD

13.4%

7.2

-4.1%

118 of 142

Live Oak Health Sciences Fund

USD

13.4%

8.0

-3.5%

119 of 142

Mediolanum Challenge Counter Cyclical Eq Fd L A

USD

13.0%

4.5

-0.2%

120 of 142

UTI Growth Sector-Pharma&Healthcare-Income

USD

12.9%

16.2

-10.2%

121 of 142

Renaissance Global Health Care Class A

USD

12.7%

8.9

-3.7%

122 of 142

Ibercaja Sanidad A, FI

USD

12.7%

6.9

-2.6%

123 of 142

UniSector: BioPharma A

USD

12.6%

7.4

-4.6%

124 of 142

ICON Healthcare Fund;S

USD

12.5%

7.5

-4.1%

125 of 142

PARVEST Health Care Innovators Classic D EUR

USD

12.5%

9.4

-5.3%

126 of 142

HealthInvest Value Fund A

USD

12.2%

3.6

-0.4%

127 of 142

AXA WF Framlington Health A USD

USD

12.1%

8.4

-3.9%

128 of 142

Saratoga Health & Biotechnology Portfolio;A

USD

12.0%

8.8

-4.2%

129 of 142

Liberte Sante

USD

11.9%

8.7

-3.8%

130 of 142

Seligson & Co Global Top 25 Pharmaceuticals A

USD

11.6%

9.2

-3.5%

131 of 142

NB Pharmafund, FI

USD

10.9%

7.9

-3.0%

132 of 142

Kinetics Medical Fund;No Load

USD

10.7%

9.0

-4.1%

133 of 142

Fidelity Select Pharmaceuticals Portfolio

USD

10.7%

8.6

-3.7%

134 of 142

FIM Rohto

USD

10.6%

7.4

-3.8%

135 of 142

Perspective Healthcare 90 USD 1

USD

10.3%

4.9

-0.8%

136 of 142

Swedbank Robur Medica

USD

10.0%

7.4

-4.2%

137 of 142

SBI Magnum Sector Funds Umbrella-Pharma-Dividend

USD

8.5%

16.4

-12.4%

138 of 142

Selectra Investments - J. Lamarck Pharma A Cap

USD

8.0%

8.5

-4.1%

139 of 142

Edmond de Rothschild Fund- Healthcare A EUR

USD

7.9%

10.1

-8.0%

140 of 142

BZ Fine Fund - Pharma A (CHF)

USD

7.1%

10.7

-5.6%

141 of 142

Atlantis China Healthcare

USD

3.5%

16.4

-8.8%

142 of 142

pb Healthcare Fund

USD

1.4%

10.0

-9.1%

Funds with less than 12 months history are below. View 1 month performance

apo Digital Health Aktien Fonds R

Bellevue BB Adamant Asia Pacific Healthcare B C

Bellevue F (Lux) BB Adamant EmMkts HlthCare B USD

Franklin Templeton SinoAm Global Healthcare Fd TWD

KGI Hospital & Dependency Related Industries TWD

MOVESTIC SICAV - Movestic Healthcare I SEK

Perspective Healthcare 90 USD 2

Variopartner SICAV Sectoral Biotech Opps IH CHF

Variopartner SICAV Sectoral Glb Healthcare Fund P


Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

Sector showdown: fighting fit in pharma

Leading the pack in pharma, Citywire Selector delves into the data.

AXA IM replaces manager on thematic fund

Investment group names new PM for gender diversity approach.

Four rated managers clash over future of robotics investing

How leading investors are adapting to the rise of automation and AI.

Why AI alone won't reshape asset management

Top investors tackle what innovation means for jobs, decision-making and thematic investing.

Insider's top tip for tapping the Internet of Things

Candriam’s Johan Van der Biest pinpoints the single item all mechanisms will need.

Swiss firm unveils EM healthcare fund

Sector specialist seeks to expand expertise with dedicated approach.

AAA-rated showcase: Wellington’s Jean Hynes

Get to know the top-rated investors in Citywire’s database.

Revealed: the most popular funds among UK multi-managers

Research from Harrington Cooper shows the most popular funds held by 32 balanced multi-manager portfolios.

The healthcare sector heading for a transformation

A-rated Stefan Blum believes reduced surgical risks is proving a winner for investors.

Selector snapshot: the UK boutique to back

Financière Arbevel’s Vincent Morel reveals the thematic investor rising up his watch list.